Skip to main content

Month: March 2021

Pathfinder Bancorp, Inc. Revises 2020 Pretax Net Income and Related Financial Information at and for the Year Ended December 31, 2020

      Decrease in Pretax Net Income Offset by a Reduction in Income Tax ExpenseNo Change to Originally Reported Net Income or Earnings Per Share Calculations OSWEGO, N.Y., March 29, 2021 (GLOBE NEWSWIRE) — Pathfinder Bancorp, Inc. (“Company”) (NASDAQ: PBHC), the holding company for Pathfinder Bank (“Bank”) issued an update to its earnings release furnished on a Current Report on Form 8-K on February 1, 2020 (the “Original Press Release”) reporting its financial results at and for the three and twelve months ended December 31, 2020. This updated Press Release (the “Updated Press Release”) is being furnished to revise pretax net income and related financial information for the three and twelve months ended December 31, 2020. Two revisions to pretax net income were made related to loan interest income and operating expenses that reduced...

Continue reading

Globus Maritime Announces Filing of its 2020 Annual Report on Form 20-F

GLYFADA, Greece, March 29, 2021 (GLOBE NEWSWIRE) — Globus Maritime Limited (“Globus,” the “Company,” “we,” or “our”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that the Company’s annual report on Form 20-F that contains the Company’s audited financial statements for the fiscal year ended December 31, 2020 was filed today with the Securities and Exchange Commission, and may be found on the Company’s website at www.globusmaritime.gr under Investor Relations. Alternatively, shareholders may receive a hard copy of the 2020 Annual Report on Form 20-F, free of charge, by request to Globus’ Investor Relations Advisor at: Capital Link Inc.230 Park Avenue, Suite 1536New York, NY 10169 USATel: (+) 1 212 661 7566Email: globus@capitallink.com About Globus Maritime Limited Globus is an integrated dry bulk...

Continue reading

Udnyttelse af warranter

Adm. direktør Michael Hove samt bestyrelsesmedlem Jakob Have har dd. meddelt selskabet, at de ønsker at udnytte deres warranter iht. warrantprogram af 15 juni 2018, hvilket giver dem ret til at tegne følgende antal aktier til 1,44.Michael Hove: 2.318.631 aktier Jakob Have 275.000 aktierSelskabet vil sælge i alt 2.593.631 aktier fra sin egenbeholdning. Kontakt:Evt. spørgsmål til denne meddelelse kan rettes til CEO Michael Hove på 28126609 eller mail mh@sca-invgroup.dk Venlig hilsenBestyrelsen Vedhæftede filer

Continue reading

Checkmate Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Update on Recent Progress

CAMBRIDGE, Mass., March 29, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced full year 2020 financial results and provided an update on recent progress. “We made strong progress in 2020, laying the groundwork to broaden and accelerate our CMP-001 clinical program in melanoma and other solid tumor indications,” said Barry Labinger, President and Chief Executive Officer of Checkmate. Recent ProgressIn December 2020, Checkmate announced a clinical collaboration with Bristol Myers Squibb to evaluate vidutolimod (formerly CMP-001) in combination with nivolumab. The companies will collaborate on two melanoma clinical trials. In January...

Continue reading

Vornado Completes $350 Million Refinancing of 909 Third Avenue

NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) — VORNADO REALTY TRUST (NYSE: VNO) announced today that it has completed a $350 million refinancing of 909 Third Avenue, a 1.4 million square foot Manhattan office building. The interest only loan bears a fixed rate of 3.23% and matures in April 2031. The loan replaces the previous $350 million loan that bore interest at a fixed rate of 3.91% and was scheduled to mature in May 2021. Vornado Realty Trust is a fully-integrated equity real estate investment trust. CONTACT Thomas Sanelli(212) 894-7000 Certain statements contained herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance...

Continue reading

Nova LifeStyle Announces Fiscal 2020 Results

LOS ANGELES, March 29, 2021 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced financial results for the fiscal year ended December 31, 2020. Tawny Lam, Chairperson and Chief Executive Officer of Nova LifeStyle, stated, “I want to emphasize our view of the Company’s importance to the communities where we have a presence throughout the globe and of our ongoing focus on keeping our employees safe while supporting customers during the pandemic. Throughout 2020, we expanded our business model while operating in the challenges posed by the COVID-19 pandemic.” Key Financial Highlights:Revenues for the year ended December 31, 2020 were $11.3 million, as compared to $21.9 million in the fiscal year for 2019. Gross Loss was $26.0 million in 2020, as compared to a gross loss of $8.6...

Continue reading

ARMOUR Residential REIT, Inc. Announces Guidance for April 2021 Dividend Rate Per Common Share

VERO BEACH, Florida, March 29, 2021 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced guidance on the April 2021 cash dividend for the Company’s Common Stock, which maintains the current monthly dividend rate of $0.10 per Common share. April 2021 Common Stock Dividend InformationMonth   Dividend   Holder of Record Date   Payment DateApril 2021   $ 0.10   April 15, 2021   April 29, 2021Certain Tax Matters ARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to...

Continue reading

Applied Molecular Transport Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., March 29, 2021 (GLOBE NEWSWIRE) — Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of 2,500,000 shares of its common stock. All of the shares in the proposed offering will be sold by AMT. In addition, AMT expects to grant the underwriters a 30-day option to purchase up to an additional 375,000 shares of its common stock in the offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering. BofA Securities, Jefferies, and SVB Leerink are acting as joint book-running managers for the proposed offering. A registration statement relating...

Continue reading

Palomar Holdings, Inc. Announces Two Year, $40 Million Share Repurchase Program

~ Company intends to repurchase shares opportunistically ~ ~ Previous communicated growth outlook remains unchanged~ LA JOLLA, Calif., March 29, 2021 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or the “Company”) today announced that its Board of Directors has approved a share repurchase program effective March 31, 2021. The program authorizes the repurchase by the Company of up to $40 million of its outstanding shares of common stock over the period ending on March 31, 2023. Under the share repurchase program, shares may be repurchased from time to time in the open market or negotiated transactions at prevailing market rates, or by other means in accordance with federal securities laws. Mac Armstrong, Chairman and Chief Executive Officer of Palomar, commented, “The Board’s authorization of the share repurchase...

Continue reading

Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

FOSTER CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided a business update. “The past year has been transformational for Vaxcyte and I am pleased with the multiple milestones we have achieved on the path to submit our Investigational New Drug (IND) application for VAX-24, our 24-valent pneumococcal conjugate vaccine (PCV), the progress of our other pipeline programs, and the addition of new leadership team members,” said Grant Pickering, Chief Executive Officer and Co-founder of Vaxcyte. “While...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.